Boston Scientific Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -40.1% | +221.1% | +181.2% | +1.7% | -33.7% | +50.2% | +6.9% | +129.2% | -49.9% | +104.3% | -49.4% | +30.2% | -31.3% | -61.1% | +210.2% | +25.0% | -14.1% | +17.3% | -52.7% | +62.0% | +46.7% | -78.3% | +492.3% | -17.9% | +24.0% | -18.4% | +64.0% | +37.2% | +32.0% | |
| – | +41.2% | +48.3% | +38.4% | +1.7% | +28.2% | -30.6% | +21.7% | +40.3% | +14.2% | +148.7% | +20.2% | -8.0% | -3.5% | -2.2% | -12.1% | -4.7% | +0.9% | +5.2% | +6.1% | +6.0% | +3.6% | +5.9% | +13.1% | +11.1% | -2.7% | +3.9% | +5.3% | +6.1% | +7.8% | |
| – | -98.2% | – | – | – | – | -68.8% | +119.5% | +43.5% | +14.2% | +1,223.3% | -97.1% | +13.1% | +4.3% | +4.2% | -14.7% | -15.6% | -2.8% | -1.9% | +3.9% | +8.4% | +9.5% | +10.2% | +12.1% | +8.3% | +14.1% | +13.4% | +5.9% | +14.2% | +12.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,989.1% | -98.2% | +13,255.9% | -87.2% | -50.9% | -38.5% | -29.0% | +100.0% | -101.6% | – | -34.3% | -51.2% | +310.0% | – | – | – | |
| – | – | – | – | -14.8% | -92.7% | -376.9% | – | – | -312.1% | – | -88.2% | -283.3% | – | -248.9% | – | – | -45.4% | +520.6% | -70.9% | -101.4% | – | -3,372.7% | – | – | -935.7% | – | – | – | – | |
| – | +76.1% | +837.9% | -96.4% | -5.0% | +59.2% | -7.4% | +67.9% | +45.7% | +24.5% | +0.0% | +6.5% | -0.3% | +0.0% | -23.2% | +9.4% | -25.7% | +8.4% | +5.7% | -4.6% | +52.2% | -15.2% | -0.9% | +45.9% | -18.4% | +47.3% | +10.5% | +30.7% | -1.2% | +10.9% | |
| – | -37.0% | +786.4% | -91.7% | -42.2% | +647.7% | -41.5% | +86.1% | +86.2% | -66.0% | +1,590.0% | -94.9% | – | -344.8% | -39.5% | – | -175.3% | -18.0% | +56.8% | +193.4% | -59.4% | +13.9% | +90.2% | +162.4% | -91.8% | +288.6% | +25.9% | +28.0% | +120.9% | -53.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +379.8% | -57.4% | -100.0% | – | – | +0.0% | +0.0% | +0.0% | +96.4% | +0.0% | -49.1% | -100.0% | – | |
| – | +193.1% | – | – | +74.8% | – | – | – | -36.8% | +103.9% | – | – | – | – | -6.1% | -1,687.1% | +22.0% | -16.7% | -75.0% | – | -2.6% | -23.4% | +18.8% | +21.8% | -535.0% | – | +23.6% | +33.8% | +26.4% | +22.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -38.2% | +137.2% | -98.5% | -47.4% | – | +3.2% | -113.3% | – | +1,042.3% | +98.9% | -135.8% | -83.5% | +0.0% | -97.6% | – | -126.9% | |
| – | -22.1% | +1,121.4% | -127.5% | +17.3% | – | -140.0% | – | -9.9% | -317.3% | – | -108.1% | +98.5% | -39.3% | -39.5% | +247.0% | -56.8% | -19.9% | -74.8% | – | -115.6% | – | +1,201.8% | +107.6% | -90.1% | -132.4% | +476.8% | – | +36,180.0% | -121.8% | |
| – | – | – | -148.4% | – | – | -23.0% | +323.7% | +52.1% | -197.1% | – | -122.1% | – | -511.1% | – | – | -211.1% | – | +3,600.0% | -172.4% | – | – | -135.8% | – | – | -87.5% | -702.3% | – | – | – | |
| – | – | – | – | +2.5% | -44.3% | +69.1% | -4.0% | +155.4% | -63.3% | +167.6% | -62.0% | +49.6% | -44.6% | -90.1% | +1,397.9% | +46.9% | -19.1% | +20.7% | -65.0% | +68.8% | +85.7% | -100.5% | – | -17.7% | +16.3% | -30.5% | +86.3% | +55.3% | +38.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.